ELTX · Elicio Therapeutics, Inc.

$2.89 -0.06 (-2.03%) At close · Jul 29

Market Cap

$56.30M

19.09M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert Connelly	CEO	$608,400	—	—	$1,093,421	$334,620	—	$2,036,441
Christopher Haqq	Executive Vice President, Head of Research and Development and Chief Medical Officer	$507,807	—	—	$205,365	$213,280	—	$926,452
Peter DeMuth	Chief Scientific Officer	$460,000	—	—	$218,071	$188,600	—	$866,671

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Venkatesan	CEO	$243,944	$608,000	—	$22,427	—	$1,554,904	$2,429,275
Jennifer J. Rhodes	General Counsel	$222,257	$440,840	—	—	—	$702,762	$1,365,859
Brian Piekos	CFO	$273,548	—	—	$501,969	$103,238	—	$878,755
Robert Connelly	CEO	$498,750	—	—	—	$179,550	—	$678,300
Christopher Haqq	Executive Vice President, Head of Research and Development and Chief Medical Officer	$488,276	—	—	—	$185,545	—	$673,821
Peter DeMuth	Chief Scientific Officer	$364,229	—	—	—	$138,407	—	$502,636

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Venkatesan	CEO	$608,000	—	—	$898,973	$11,876	—	$1,518,849
Robert Connelly	CEO	$475,000	—	—	$572,040	$209,000	—	$1,256,040
Christopher Haqq	Executive Vice President, Head of Research and Development and Chief Medical Officer	$465,025	—	—	$511,321	$186,010	—	$1,162,356
Jennifer J. Rhodes	General Counsel	$440,840	—	—	$320,613	$12,200	—	$773,653

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Venkatesan	CEO	$587,100	—	—	$1,952,099	—	—	$2,539,199
Itzhak D. Goldberg	Chairman	$484,018	—	—	$763,863	—	—	$1,247,881
John F. Neylan	Executive Vice President and Chief Medical Officer	$468,650	—	—	$763,863	—	—	$1,232,513

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jay R. Venkatesan	CEO	$570,000	$194,800	—	$629,598	—	—	$1,394,398

Key facts CIK 1601485 CUSIP 28657F103 13F (30d) 11 filings 11 filers Visit website Investor relations